adamkaz TD Cowen projected a positive outlook for Life Science Tools and Diagnostics stocks on Friday despite the sector's underperformance since President-elect Donald Trump's successful reelection bid. Analyst Dan Brennan's comments coincide with the healthcare sector's concerns over Trump's proposal to.